Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Carvedilol NDC 68788-7910 by Preferred Pharmaceuticals Inc.,, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carvedilol Tablets 25mg - D5E4E1B9 8541 41EB BE1C BE76BE171B4B 00

Carvedilol Tablets 25mg - D5E4E1B9 8541 41EB BE1C BE76BE171B4B 00

Carvedilol Tablets are available with a prescription for patients suffering from heart failure and high blood pressure. However, transferring this medication to anyone other than the patient is prohibited by federal law. This drug is a generic equivalent for Coreg and manufactured by Glenmark Pharmaceuticals Inc. Each tablet contains 25mg of Carvedilol. The package includes the production date, expiration date, and lot number for quality assurance purposes. The text also includes a log chart for patient records.*

figure-1 - figure 1

figure-1 - figure 1

This seems to be a graph or chart with three labels: "Placebo", "Carvedilol", and "P=0.0014". There is also a time axis marked at intervals of 3 months up to 21 months. Without additional context, it is not possible to determine the meaning of this data or its significance.*

figure-2 - figure 2

figure-2 - figure 2

figure-3 - figure 3

figure-3 - figure 3

The text describes a figure showcasing the survival analysis for CAPRICORN. The graph includes a comparison between the placebo and carvedilol groups, with the x-axis measuring the duration of time (in months) and the y-axis measuring the number of participants. There is a significant difference between the placebo and carvedilol groups, with a p-value of 0.03, indicating that the use of carvedilol led to improved survival rates.*

figure-4 - figure 4

figure-4 - figure 4

The text provided contains a table showing the effects on mortality for subgroups in the CAPRICORN study. The table is divided into various subgroups such as age, gender, medications taken during MI, randomized day of MI, hypertension, diabetes, Killip status, heart rate, thrombolytic use, and PTCA for MI, with corresponding hazard ratios for each subgroup.*

carvedilol-chemical-structure - structure

carvedilol-chemical-structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.